⌘K

Login Start Free

Home/Filings/4/0001061983-25-000048

4//SEC Filing

Callos Andrew 4

Accession 0001061983-25-000048

CIK 0001061983other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 5:35 PM ET

Size

18.4 KB

Accession

0001061983-25-000048

Insider Transaction Report

Form 4

Period: 2025-12-05

CYTOKINETICS INCCYTK

EVP, Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
2025-12-05$23.26/sh+15,000$348,900→ 65,660 total
Exercise/Conversion
Common Stock
2025-12-05$39.13/sh+11,000$430,430→ 76,660 total
Exercise/Conversion
Common Stock
2025-12-05$37.63/sh+15,858$596,737→ 92,518 total
Exercise/Conversion
Common Stock
2025-12-05$37.63/sh+10,628$399,932→ 103,146 total
Sale
Common Stock
2025-12-05$65.95/sh−52,486$3,461,452→ 50,660 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-12-05−15,000→ 114,000 total
Exercise: $23.26From: 2022-03-31Exp: 2031-03-31→ Common Stock (15,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-12-05−11,000→ 36,445 total
Exercise: $39.13From: 2023-04-06Exp: 2033-03-06→ Common Stock (11,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2025-12-05−15,858→ 15,857 total
Exercise: $37.63From: 2025-04-01Exp: 2032-03-01→ Common Stock (15,858 underlying)
Exercise/Conversion
Incentive Stock Option (Right to Buy)
2025-12-05−10,628→ 2,657 total
Exercise: $37.63From: 2025-04-01Exp: 2032-03-01→ Common Stock (10,628 underlying)

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1

filerCIK 0001852129

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 5:35 PM ET
Size: 18.4 KB

View on SEC.gov